EGF regulates plasminogen activator inhibitor-1 (PAI-1) by a pathway involving c-Src, PKCδ, and sphingosine kinase 1 in glioblastoma cells

FASEB Journal

Volumn 22, Issue 2, 2008, Pages 455-465

  Paugh, Barbara S ^a   Paugh, Steven W ^a   Bryan, Lauren ^a   Kapitonov, Dmitri ^a   Wilczynska, Katarzyna M ^a   Gopalan, Sunita M ^a   Rokita, Hanna ^b   Milstien, Sheldon ^c   Spiegel, Sarah ^a   Kordula, Tomasz ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Glioma; Invasiveness

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 2,5 PYRROLIDINEDIONE; 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 [1 (3 DIMETHYLAMINOPROPYL) 5 METHOXY 1H INDOL 3 YL] 3 (1H INDOL 3 YL)MALEIMIDE; 2 MORPHOLINO 8 PHENYLCHROMONE; 3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; DACTINOMYCIN; EPIDERMAL GROWTH FACTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN KINASE C DELTA; SPHINGOSINE KINASE 1; STAUROSPORINE;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; GLIOBLASTOMA; HUMAN; HUMAN CELL; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION;

CELL LINE, TUMOR; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION REGULATION; GLIOBLASTOMA; HUMANS; NF-KAPPA B; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN KINASE C-ALPHA; PROTEIN KINASE C-DELTA; PROTO-ONCOGENE PROTEINS PP60(C-SRC); SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR AP-1;

EID: 38949105094     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.07-8276com     Document Type: Article

References (50)

1. Bellail, A. C., Hunter, S. B., Brat, D. J., Tan, C., and Van Meir, E. G. (2004) Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int. J. Biochem. Cell Biol. 36, 1046-1069
2. Mueller, M. M., Werbowetski, T., and Del Maestro, R. F. (2003) Soluble factors involved in glioma invasion. Acta Neurochir. (Wien). 145, 999-1008
3. Nakada, M., Okada, Y., and Yamashita, J. (2003) The role of matrix metalloproteinases in glioma invasion. Front. Biosci. 8, e261-269
4. Andreasen, P. A., Egelund, R., and Petersen, H. H. (2000) The plasminogen activation system in tumor growth, invasion, and metastasis. Cell. Mol. Life Sci. 57, 25-40
5. Rooprai, H. K., and McCormick, D. (1997) Proteases and their inhibitors in human brain tumours: a review. Anticancer Res. 17, 4151-4162
6. Levicar, N., Nuttall, R. K., and Lah, T. T. (2003) Proteases in brain tumour progression. Acta Neurochir. (Wien) 145, 825-838
7. Landau, B. J., Kwaan, H. C., Verrusio, E. N., and Brem, S. S. (1994) Elevated levels of urokinase-type plasminogen activator and plasminogen activator inhibitor type-1 in malignant human brain tumors. Cancer Res. 54, 1105-1108
8. Preissner, K. T., Kanse, S. M., and May, A. E. (2000) Urokinase receptor: a molecular organizer in cellular communication. Curr. Opin. Cell Biol. 12, 621-628
9. Nagamine, Y., Medcalf, R. L., and Munoz-Canoves, P. (2005) Transcriptional and posttranscriptional regulation of the plasminogen activator system. Thromb. Haemost. 93, 661-675
10. Kasza, A., Kowanetz, M., Poslednik, K., Witek, B., Kordula, T., and Koj, A. (2001) Epidermal growth factor and pro-inflammatory cytokines regulate the expression of components of plasminogen activation system in U373-MG astrocytoma cells. Cytokine 16, 187-190
11. Kasza, A., Kiss, D. L., Gopalan, S., Xu, W., Rydel, R. E., Koj, A., and Kordula, T. (2002) Mechanism of plasminogen activator inhibitor-1 regulation by oncostatin M and interleukin-1 in human astrocytes. J. Neurochem. 83, 696-703
12. Plata-Salaman, C. R. (1991) Epidermal growth factor and the nervous system. Peptides 12, 653-663
13. Wong, A. J., Bigner, S. H., Bigner, D. D., Kinzler, K. W., Hamilton, S. R., and Vogelstein, B. (1987) Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc. Natl. Acad. Sci. U. S. A. 84, 6899-6903
14. Libermann, T. A., Nusbaum, H. R., Razon, N., Kris, R., Lax, I., Soreq, H., Whittle, N., Waterfield, M. D., Ullrich, A., and Schlessinger, J. (1985) Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature 313, 144-147
15. Frederick, L., Wang, X. Y., Eley, G., and James, C. D. (2000) Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas. Cancer Res. 60, 1383-1387
16. Von Deimling, A., Louis, D. N., von Ammon, K., Petersen, I., Hoell, T., Chung, R. Y., Martuza, R. L., Schoenfeld, D. A., Yasargil, M. G., Wiestler, O. D., and Seizinger, B. R. (1992) Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme. J. Neurosurg. 77, 295-301
17. Quan, A. L., Barnett, G. H., Lee, S. Y., Vogelbaum, M. A., Toms, S. A., Staugaitis, S. M., Prayson, R. A., Peereboom, D. M., Stevens, G. H., Cohen, B. H., and Suh, J. H. (2005) Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiforme. Int. J. Radiat. Oncol. Biol. Phys. 63, 695-703
18. Muracciole, X., Romain, S., Dufour, H., Palmari, J., Chinot, O., Ouafik, L., Grisoli, F., Branger, D. F., and Martin, P. M. (2002) PAI-1 and EGFR expression in adult glioma tumors: toward a molecular prognostic classification. Int. J. Radiat. Oncol. Biol. Phys. 52, 592-598
19. Valter, M. M., Wiestler, O. D., and Pietsche, T. (1999) Differential control of VEGF synthesis and secretion in human glioma cells by IL-1 and EGF. Int. J. Dev. Neurosci. 17, 565-577
20. Hjortland, G. O., Lillehammer, T., Somme, S., Wang, J., Halvorsen, T., Juell, S., Hirschberg, H., Fodstad, O., and Engebraaten, O. (2004) Plasminogen activator inhibitor-1 increases the expression of VEGF in human glioma cells. Exp. Cell Res. 294, 130-139
21. Mazar, A. P., Henkin, J., and Goldfarb, R. H. (1999) The urokinase plasminogen activator system in cancer: implications for tumor angiogenesis and metastasis. Angiogenesis 3, 15-32
22. Lakka, S. S., Gondi, C. S., Dinh, D. H., Olivero, W. C., Gujrati, M., Rao, V. H., Sioka, C., and Rao, J. S. (2005) Specific interference of urokinase-type plasminogen activator receptor and matrix metalloproteinase-9 gene expression induced by double-stranded RNA results in decreased invasion, tumor growth, and angiogenesis in gliomas. J. Biol. Chem. 280, 21882-21892
23. Rao, J. S., Gondi, C., Chetty, C., Chittivelu, S., Joseph, P. A., and Lakka, S. S. (2005) Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of anti-sense uPAR and MMP-9 in non-small cell lung cancer cells. Mol. Cancer Ther. 4, 1399-1408
24. Foekens, J. A., Peters, H. A., Look, M. P., Portengen, H., Schmitt, M., Kramer, M. D., Brunner, N., Janicke, F., Meijer-van Gelder, M. E., Henzen-Logmans, S. C., van Putten, W. L., and Klijn, J. G. (2000) The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients. Cancer Res. 60, 636-643
25. Czekay, R. P., Aertgeerts, K., Curriden, S. A., and Loskutoff, D. J. (2003) Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins. J. Cell Biol. 160, 781-791
26. Czekay, R. P., and Loskutoff, D. J. (2004) Unexpected role of plasminogen activator inhibitor 1 in cell adhesion and detachment. Exp. Biol. Med. (Maywood) 229, 1090-1096
27. Gopalan, S., Kasza, A., Xu, W., Kiss, D. L., Wilczynska, K. M., Rydel, R. E., and Kordula, T. (2005) Astrocyte- and hepatocyte-specific expression of genes from the distal serpin subcluster at 14q32.1 associates with tissue-specific chromatin structures. J. Neurochem. 94, 763-773
28. Feinberg, A. P., and Vogelstein, B. (1983) A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132, 6-13
29. Kordula, T., Rydel, R. E., Brigham, E. F., Horn, F., Heinrich, P. C., and Travis, J. (1998) Oncostatin M and the interleukin-6 and soluble interleukin-6 receptor complex regulate alpha1-antichymotrypsin expression in human cortical astrocytes. J. Biol. Chem. 273, 4112-4118
30. Baeuerle, P. A., and Baltimore, D. (1988) I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 242, 540-546
31. Sawadogo, M., Van Dyke, M. W., Gregor, P. D., and Roeder, R. G. (1988) Multiple forms of the human gene-specific transcription factor USF. I. Complete purification and identification of USF from HeLa cell nuclei. J. Biol. Chem. 263, 11985-11993
32. Bektas, M., Jolly, P. S., Muller, C., Eberle, J., Spiegel, S., and Geilen, C. C. (2005) Sphingosine kinase activity counteracts ceramide-mediated cell death in human melanoma cells: role of Bcl-2 expression. Oncogene 24, 178-187
33. Hou, B., Eren, M., Painter, C. A., Covington, J. W., Dixon, J. D., Schoenhard, J. A., and Vaughan, D. E. (2004) Tumor necrosis factor alpha activates the human plasminogen activator inhibitor-1 gene through a distal nuclear factor kappaB site. J. Biol. Chem. 279, 18127-18136
34. Samad, F., Hester, K. D., Yang, G., Hannun, Y. A., and Bielawski, J. (2006) Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk. Diabetes 55, 2579-2587
35. Spiegel, S., and Milstien, S. (2003) Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat. Rev. Mol. Cell Biol. 4, 397-407
36. Pitson, S. M., Xia, P., Leclercq, T. M., Moretti, P. A., Zebol, J. R., Lynn, H. E., Wattenberg, B. W., and Vadas, M. A. (2005) Phosphorylation- dependent translocation of sphingosine kinase to the plasma membrane drives its oncogenic signalling. J. Exp. Med. 201, 49-54
37. Mizuno, K., Kubo, K., Saido, T. C., Akita, Y., Osada, S., Kuroki, T., Ohno, S., and Suzuki, K. (1991) Structure and properties of a ubiquitously expressed protein kinase C, nPKC delta. Eur. J. Biochem. 202, 931-940
38. Benes, C. H., Wu, N., Elia, A. E., Dharia, T., Cantley, L. C., and Soltoff, S. P. (2005) The C2 domain of PKCdelta is a phosphotyrosine binding domain. Cell 121, 271-280
39. Janicke, F., Schmitt, M., and Graeff, H. (1991) Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type 1 inhibitor in breast cancer. Semin. Thromb. Hemost. 17, 303-312
40. Hopkins, W. E., Westerhausen, D. R., Jr., Sobel, B. E., and Billadello, J. J. (1991) Transcriptional regulation of plasminogen activator inhibitor type-1 mRNA in Hep G2 cells by epidermal growth factor. Nucleic Acids Res. 19, 163-168
41. Anteby, E. Y., Greenfield, C., Natanson-Yaron, S., Goldman-Wohl, D., Hamani, Y., Khudyak, V., Ariel, I., and Yagel, S. (2004) Vascular endothelial growth factor, epidermal growth factor and fibroblast growth factor-4 and -10 stimulate trophoblast plasminogen activator system and metalloproteinase-9. Mol. Hum. Reprod. 10, 229-235
42. Mawatari, M., Okamura, K., Matsuda, T., Hamanaka, R., Mizoguchi, H., Higashio, K., Kohno, K., and Kuwano, M. (1991) Tumor necrosis factor and epidermal growth factor modulate migration of human microvascular endothelial cells and production of tissue-type plasminogen activator and its inhibitor. Exp. Cell Res. 192, 574-580
43. Seebacher, T., Manske, M., Zoller, J., Crabb, J., and Bade, E. G. (1992) The EGF-inducible protein EIP-1 of migrating normal and malignant rat liver epithelial cells is identical to plasminogen activator inhibitor 1 and is a component of the ECM migration tracks. Exp. Cell Res. 203, 504-507
44. Samarakoon, R., Higgins, C. E., Higgins, S. P., Kutz, S. M., and Higgins, P. J. (2005) Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK- dependent. J. Cell Physiol. 204, 236-246
45. Guerrero, J., Santibanez, J. F., Gonzalez, A., and Martinez, J. (2004) EGF receptor transactivation by urokinase receptor stimulus through a mechanism involving Src and matrix metalloproteinases. Exp. Cell Res. 292, 201-208
46. Van Brocklyn, J. R., Jackson, C. A., Pearl, D. K., Kotur, M. S., Snyder, P. J., and Prior, T. W. (2005) Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: roles of sphingosine kinase isoforms in growth of glioblastoma cell lines. J. Neuropathol. Exp. Neurol. 64, 695-705
47. Van Brocklyn, J. R., Young, N., and Roof, R. (2003) Sphingosine-1- phosphate stimulates motility and invasiveness of human glioblastoma multiforme cells. Cancer Lett. 199, 53-60
48. Van Brocklyn, J. R., Lee, M. J., Menzeleev, R., Olivera, A., Edsall, L., Cuvillier, O., Thomas, D. M., Coopman, P. J., Thangada, S., Liu, C. H., Hla, T., and Spiegel, S. (1998) Dual actions of sphingosine-1-phosphate: extracellular through the Gi-coupled receptor Edg-1 and intracellular to regulate proliferation and survival. J. Cell Biol. 142, 229-240
49. Angers-Loustau, A., Hering, R., Werbowetski, T. E., Kaplan, D. R., and Del Maestro, R. F. (2004) SRC regulates actin dynamics and invasion of malignant glial cells in three dimensions. Mol. Cancer Res. 2, 595-605
50. Yamaguchi, K., Richardson, M. D., Bigner, D. D., and Kwatra, M. M. (2005) Signal transduction through substance P receptor in human glioblastoma cells: roles for Src and PKCdelta. Cancer Chemother. Pharmacol. 56, 585-593